Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Esteve Pharmaceuticals, S.A.

https://www.esteve.com/

Latest From Esteve Pharmaceuticals, S.A.

Finance Watch: Rivus Raises $132m In Series B Cash To Fund Obesity Drug Trials

VC funding slowed recently, but public company financings kept up a brisk pace with follow-on public offerings for Allakos and Alpine, private placements for Ventyx and Syros, and Albireo’s royalty deal. In restructuring updates, Biogen raised $592m in a real estate deal and Acerus is assessing options.

Financing Growth

Keeping Track: US FDA Clears New Uses For Incyte’s Pemazyre, AbbVie’s Imbruvica; Minerva Seeks First Negative Symptoms Claim In Schizophrenia

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

United States BioPharmaceutical

Waiting Game For Minerva After Roluperidone US Filing

The firm’s potential new therapy for the negative symptoms of schizophrenia is now in the hands of the US Food and Drug Administration – some have concerns over whether the supporting data will be enough.

Companies Approvals

Psychiatric Disorders Markets: Depression, Bipolar Disorder And Schizophrenia

PODCAST: Datamonitor Healthcare analysts explore the three key psychiatric disorder markets from current market leaders to promising pipeline candidates and novel mechanisms.

Neurology Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Contract Manufacturing Organization
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Esteve Teijin Healthcare (ETH)
    • Laboratorios del Dr. Esteve, S.A.
UsernamePublicRestriction

Register